layout image layout image
 
Diabetic Cooking header image

Diabetes Mellitus Links


Oral Drug Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline ... - Annals of Internal Medicine

Scientists Rate Metabolic Breathalyzer Technique Better Than Blood Tests for ... - International Business Times

Diabetes Mellitus Drug from Amylin Gets FDA Approval - ThirdAge

Role of Antidiabetics in Pancreatic Cancer Risk Unclear - Medscape

Diabetes Mellitus Amputations Down in U.S. - ThirdAge

<< 1 2 3 >>


 

Diabetic Cooking Recommended Products
Diabetes Mellitus News

Diabetes Mellitus Drugs May Raise Risk for Pancreatic Cancer

Taking certain diabetes mellitus drugs may put you at higher risk for developing pancreatic cancer, a new Swiss study from the University Hospital Basel shows. According to Reuters Health, only the drug metformin seems to decrease the risk of multiple cancers—and only in women.

Read more...


Diabetes Mellitus Amputations Down in U.S.

Severe cases of diabetes mellitus will often lead doctors to amputate some of the lower limbs, but new data from federal health officials show that the number of foot and leg amputations in the U.S. is falling. According to UPI, the rate of amputation for American diabetics age 40 and older dropped 65 percent from 1996 to 2008. The data comes from a study performed by the Centers for Disease ...

Read more...


Diabetes Mellitus Patients Facing Fewer Amputations

  People with diabetes mellitus were once fairly likely to lose a foot or leg, but new research shows that the risk of amputations has declined dramatically since the mid-1990s. The Centers for Disease Control and Prevention reported Tuesday that that hospital discharge rates for lower-extremity amputation among diabetics age 40 and older fell an average of 8.6 percent per year between 1996 and ...

Read more...


Seasonal changes may influence the efficacy of vaccination against diabetes

The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase three trials that failed to show significant effects. One possible explanation may be seasonal variations in the immune system, claim those responsible for the study that was published in the New England Journal of Medicine.

Read more...


Diabetes Mellitus Drug from Amylin Gets FDA Approval

Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes mellitus drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old product, Byetta.

Read more...


 
layout image layout image